Clinical Trial Update: A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia. [Phase 3]

View source ↗

Summary

This document reports the termination of a Phase 3 randomized trial evaluating post-remission therapy in elderly patients with Acute Myeloid Leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Acute Leukemia French Association | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: TERMINATED